1. Home
  2. BUUU vs SLGL Comparison

BUUU vs SLGL Comparison

Compare BUUU & SLGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BUUU

BUUU Group Limited Class A Ordinary Share

N/A

Current Price

$28.86

Market Cap

305.2M

ML Signal

N/A

Logo Sol-Gel Technologies Ltd.

SLGL

Sol-Gel Technologies Ltd.

N/A

Current Price

$83.21

Market Cap

268.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BUUU
SLGL
Founded
2017
1997
Country
Hong Kong
Israel
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
305.2M
268.9M
IPO Year
2024
2016

Fundamental Metrics

Financial Performance
Metric
BUUU
SLGL
Price
$28.86
$83.21
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$110.00
AVG Volume (30 Days)
56.4K
37.8K
Earning Date
05-18-2026
05-22-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$223.84
P/E Ratio
$347.19
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.97
$14.78
52 Week High
$32.97
$97.97

Technical Indicators

Market Signals
Indicator
BUUU
SLGL
Relative Strength Index (RSI) 67.70 50.26
Support Level $14.04 $67.53
Resistance Level N/A $94.33
Average True Range (ATR) 2.91 5.57
MACD 0.56 -0.20
Stochastic Oscillator 64.29 34.36

Price Performance

Historical Comparison
BUUU
SLGL

About BUUU BUUU Group Limited Class A Ordinary Share

BUUU Group Ltd provides comprehensive meetings, incentives, conferences, and exhibitions (MICE) solutions focused on event management and stage production. Its event management team offers creative planning, project management, and on-site supervision for a wide range of cultural, artistic, recreational, and corporate events, working closely with clients and partners. The stage production team creates immersive event experiences by managing lighting, audio-visual systems, stage performance elements, and venue decorations, overseeing the entire production process. Event management generates the majority of revenue.

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted. It generates the majority of its revenue from the United States.

Share on Social Networks: